VCM
MDT icon

Versant Capital Management’s Medtronic MDT Stock Holding History

Versant Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Sell
3,816
-1,464
-28% -$118K 0.03% 470
2026
Q1 		$458K Sell
5,280
-3,752
-42% -$359K 0.05% 287
2025
Q4 		$868K Buy
9,032
+982
+12% +$95.4K 0.11% 108
2025
Q3 		$767K Buy
8,050
+381
+5% +$35K 0.1% 115
2025
Q2 		$669K Buy
7,669
+2,962
+63% +$251K 0.1% 118
2025
Q1 		$423K Buy
4,707
+2,919
+163% +$261K 0.07% 193
2024
Q4 		$143K Buy
1,788
+238
+15% +$20.6K 0.03% 233
2024
Q3 		$140K Buy
1,550
+344
+29% +$28.9K 0.03% 187
2024
Q2 		$94.9K Buy
1,206
+1,182
+4,925% +$96.9K 0.02% 218
2024
Q1 		$2.09K Hold
24
– – ﹤0.01% 1332
2023
Q4 		$1.98K Sell
24
-141
-85% -$10.7K ﹤0.01% 1290
2023
Q3 		$12.9K Buy
165
+20
+14% +$1.67K ﹤0.01% 635
2023
Q2 		$12.8K Buy
145
+52
+56% +$4.48K ﹤0.01% 675
2023
Q1 		$7.5K Buy
93
+81
+675% +$6.6K ﹤0.01% 811
2022
Q4 		$933 Hold
12
– – ﹤0.01% 1310
2022
Q3 		$1K Hold
12
– – ﹤0.01% 1285
2022
Q2 		$1K Sell
12
-30
-71% -$3.04K ﹤0.01% 1302
2022
Q1 		$5K Sell
42
-255
-86% -$26.9K ﹤0.01% 886
2021
Q4 		$31K Sell
297
-2
-0.7% -$232 0.01% 354
2021
Q3 		$37K Buy
299
+7
+2% +$906 0.01% 296
2021
Q2 		$36K Sell
292
-45
-13% -$5.65K 0.01% 308
2021
Q1 		$40K Hold
337
– – 0.01% 344
2020
Q4 		$39K Buy
337
+97
+40% +$10.7K 0.02% 315
2020
Q3 		$24K Buy
240
+3
+1% +$301 0.01% 377
2020
Q2 		$21K Buy
237
+62
+35% +$5.95K 0.01% 402
2020
Q1 		$15K Sell
175
-179
-51% -$19K 0.01% 459
2019
Q4 		$40K Buy
354
+148
+72% +$16.2K 0.02% 259
2019
Q3 		$22K Hold
206
– – 0.01% 432
2019
Q2 		$20K Sell
206
-10
-5% -$913 0.01% 471
2019
Q1 		$19K Sell
216
-4
-2% -$358 0.01% 638
2018
Q4 		$20K Hold
220
– – 0.01% 540
2018
Q3 		$21K Sell
220
-6
-3% -$555 0.01% 612
2018
Q2 		$19K Buy
226
+71
+46% +$5.93K 0.01% 643
2018
Q1 		$12K Sell
155
-51
-25% -$4.21K 0.01% 836
2017
Q4 		$16K Sell
206
-1,479
-88% -$118K 0.01% 744
2017
Q3 		$131K Sell
1,685
-51
-3% -$4.23K 0.07% 102
2017
Q2 		$154K Buy
1,736
+17
+1% +$1.43K 0.08% 90
2017
Q1 		$138K Sell
1,719
-14
-0.8% -$1.09K 0.08% 100
2016
Q4 		$123K Sell
1,733
-267
-13% -$21K 0.07% 107
2016
Q3 		$172K Buy
2,000
+78
+4% +$6.8K 0.1% 85
2016
Q2 		$166K Buy
1,922
+114
+6% +$9.22K 0.1% 82
2016
Q1 		$135K Buy
1,808
+94
+5% +$7.08K 0.08% 94
2015
Q4 		$131K Buy
+1,714
New +$129K 0.08% 96

Other funds holding MDT

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Versant Capital Management's MDT Position: Q2 2026 in Review

Versant Capital Management reduced its Medtronic (MDT) stake by 28% in Q2 2026, selling an estimated $118K and leaving 3,816 shares worth $299K. The position accounts for 0.03% of the portfolio, ranked #470.

Versant Capital Management first reported a position in MDT in Q4 2015 and has held it in 43 quarters since. The position peaked at $868K in Q4 2025. 425 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Versant Capital Management held 3,816 shares of Medtronic worth $299K as of Q2 2026.
  • Versant Capital Management sold 1,464 Medtronic shares in Q2 2026, an estimated $118K.
  • Medtronic made up 0.03% of Versant Capital Management's portfolio in Q2 2026, its #470 holding.
  • Versant Capital Management first reported a position in Medtronic in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's Medtronic position peaked at $868K in Q4 2025.
  • 425 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.